[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100619300":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":8,"centralContacts":13,"locations":23,"responsibleParty":36,"collaborators":7,"id":38,"slug":7,"hasResults":39,"nctId":40,"briefTitle":41,"officialTitle":42,"acronym":43,"eligibilityCriteria":44,"healthyVolunteers":45,"sex":46,"minAge":47,"maxAge":7,"enrollmentInfo":48,"targetDuration":51,"studyType":52,"phases":7,"briefSummary":53,"conditions":54,"keywords":56,"overallStatus":61,"whyStopped":7,"lastUpdateSubmitDate":62,"lastUpdatePostDateStruct":63,"startDateStruct":66,"completionDateStruct":67,"leadSponsor":69,"locationsCount":70},{"fullName":5,"class":6},"Institute of Tropical Medicine, Belgium","OTHER",null,[9],{"name":10,"affiliation":11,"role":12},"Laurens Liesenborghs, MD","Institute of Tropical Medicine Antwerp","PRINCIPAL_INVESTIGATOR",[14,19],{"name":15,"role":16,"phone":17,"phoneExt":7,"email":18},"Christophe Van Dijck, PhD","CONTACT","+32 3 345 58 65","cvandijck@itg.be",{"name":20,"role":16,"phone":21,"phoneExt":7,"email":22},"Clinical Trials Unit Antwerp","+32 3 247 66 66","studies@itg.be",[24],{"facility":25,"status":7,"city":26,"state":7,"zip":27,"country":28,"countryCode":29,"cosmosGeoPoint":30,"geoPoint":35,"contacts":7},"Institute of Tropical Medicine","Antwerp","2000","Belgium","BE",{"type":31,"coordinates":32},"Point",[33,34],4.40026,51.22047,{"lat":34,"lon":33},{"type":37,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100619300",false,"NCT07342829","Prospective Follow-up After MVA-BN Booster Vaccination","Prospective On-site Study for the Immunological Follow-up of Individuals Who Received Booster Vaccination With MVA-BN Against Mpox","POQS-Boosted","Inclusion Criteria:\n\n1. Is scheduled to receive a booster dose of MVA-BN\n2. ≥18 years\n3. Willingness to provide written informed consent\n4. Willingness to follow the study schedule\n\nExclusion Criteria:\n\n1\\. Past or current MPXV infection",true,"ALL","18 Years",{"count":49,"type":50},95,"ESTIMATED","2 Years","OBSERVATIONAL","POQS-Boosted is a prospective observational study during which individuals who received Booster vaccination against mpox with the MVA-BN vaccine will be invited to provide biological samples at multiple times over the course of two years.",[55],"Monkeypox (Mpox)",[57,58,59,60],"mpox","immunology","vaccination","booster","NOT_YET_RECRUITING","2026-01-15",{"date":64,"type":65},"2026-01-20","ACTUAL",{"date":62,"type":50},{"date":68,"type":50},"2028-06-30",{"name":5,"class":6},1]